NCT01275794已完成不适用
Screening Epidemiological Program on Compensation Evaluation of DM Type 2 Patients on OAD Monotherapy and Physicians Satisfaction of Their Usage
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,849
- 试验地点
- 1
- 主要终点
- To assess levels of compensation of T2D by HbA1c levels in patients on OAD monotherapy
研究概览
简要总结
The purpose of the study is assessment of glycemic control and physicians satisfaction with results of DM2 OAD monotherapy
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 35 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients have an established diagnosis of T2D
- •Experience of therapy with one OAD during the from 6 months to 5 years before the registration in the Program
排除标准
- •Experience of therapy with two or more OADs and/or insulin therapy and/or incretin mimetics (exenatide) at any time before registration in the Program
- •Absence of changes in HbAc1 level during the last year before registration in the Program
结局指标
主要结局
To assess levels of compensation of T2D by HbA1c levels in patients on OAD monotherapy
时间窗: 1 visit within 4 month
To assess frequency of target levels of HbA1c ≤ 7% in patients with T2D during OAD monotherapy
时间窗: 1 visit within 4 month
次要结局
- To assess fasting glycemia in patients with T2D on OAD monotherapy(1 visit within 4 month)
- To assess postprandial levels of glycemia in patients with T2D during OAD monotherapy(1 visit within 4 month)
- To evaluate the physicians' satisfaction with the results of OAD monotherapy in patients with Typ 2 Diabetes (T2D)(1 visit within 4 month)
- To compare the results of OAD monotherapy in different groups of patients(1 visit within 4 month)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Type 2 Continuous Glucose Monitoring AcademyType 2 DiabetesNCT06516640Children's Hospital Los Angeles60
已完成
不适用
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2NCT00670722Novo Nordisk A/S6,500
已完成
不适用
Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes MellitusDiabetesDiabetes Mellitus, Type 2NCT00687284Novo Nordisk A/S2,188
已完成
不适用
Clinical Assessment of an in-Patient Glucose Monitoring System (Accu-Chek Inform Cobas IT 1000)Blood GlucoseHospital Information SystemsMedical DeviceDiabetes MellitusNCT00486681University Hospital, Grenoble949
已完成
不适用
Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.DiabetesDiabetes Mellitus, Type 2NCT00793273Novo Nordisk A/S1,074